Gland and Hormone Related Diseases

Paid Clinical Trials and Focus Groups



Find Paid Clinical Trials

Paid Clinical Trials - : Gland and Hormone




  • Condition:   Pregnancy Rate
    Interventions:   Drug: Leuveris;   Drug: Leuveris
    Sponsor:   The Baruch Padeh Medical Center, Poriya
    Not yet recruiting - verified November 2009

  • Condition:   Breast Cancer
    Intervention:   Drug: Anastrozole
    Sponsor:   Federal University of São Paulo
    Completed - verified November 2009

  • Condition:   Moderate to Severe Vasomotor Symptoms
    Interventions:   Drug: MK6913;   Drug: Comparator: 17beta-estradiol;   Drug: Comparator: placebo;   Drug: Comparator: MK6913
    Sponsor:   Merck
    Not yet recruiting - verified November 2009

  • Condition:   Breast Cancer
    Interventions:   Drug: IGF-1R inhibitor OSI-906;   Drug: erlotinib hydrochloride;   Drug: goserelin;   Drug: letrozole
    Sponsors:   Vanderbilt-Ingram Cancer Center;   National Cancer Institute (NCI)
    Not yet recruiting - verified November 2009

  • Condition:   Metastatic Prostate Cancer
    Interventions:   Dietary Supplement: phytochemical;   Drug: Docetaxel
    Sponsor:   Centre Jean Perrin
    Recruiting - verified November 2009

  • Condition:   Eosinophilic Esophagitis
    Interventions:   Drug: Beclomethasone dipropionate;   Drug: placebo
    Sponsor:   Penn State University
    Not yet recruiting - verified November 2009

  • Condition:   Healthy
    Interventions:   Drug: MK0773;   Drug: Comparator: testosterone enanthate;   Drug: Comparator: placebo oral tablet;   Drug: Comparator: placebo injection
    Sponsor:   Merck
    Completed - verified November 2009

  • Conditions:   Stress;   Pain
    Intervention:   Drug: Remifentanil
    Sponsors:   Leiden University Medical Center;   Leuven University Medical Center
    Completed - verified November 2009

  • Condition:   Healthy
    Interventions:   Drug: ACP-001 (TransCon PEG hGH);   Drug: ACP-001 (TransCon PEG hGH);   Drug: ACP-001 (TransCon PEG hGH);   Drug: ACP-001 (TransCon PEG hGH);   Drug: Placebo;   Drug: Human Growth Hormone
    Sponsor:   Ascendis Pharma A/S
    Active, not recruiting - verified November 2009

  • Conditions:   Dwarfism, Pituitary;   Hypopituitarism
    Intervention:   Drug: somatropin
    Sponsor:   Novo Nordisk
    Enrolling by invitation - verified November 2009

  • Condition:   Carpal Tunnel Syndrome
    Interventions:   Other: Acupuncture;   Drug: Prednisolone
    Sponsor:   Kuang Tien General Hospital
    Completed - verified November 2009

  • Condition:   Ovarian Hyperstimulation Syndrome
    Interventions:   Drug: Methylprednisolone;   Drug: Control
    Sponsor:   Royan Institute
    Recruiting - verified November 2009

  • Conditions:   Hypophosphatemia;   Renal Transplant
    Interventions:   Drug: Cinacalcet;   Drug: Placebo
    Sponsor:   Montefiore Medical Center
    Recruiting - verified November 2009

  • Conditions:   Nausea;   Vomiting
    Intervention:   Drug: saline, ramosetron, dexamethasone
    Sponsor:   Yonsei University
    Completed - verified November 2009

  • Condition:   Hypopituitarism
    Intervention:   Drug: Human Growth hormone - nutropin
    Sponsors:   Stanford University;   Genentech
    Recruiting - verified November 2009

  • Condition:   Prostate Cancer
    Interventions:   Other: Imaging Investigations (not radiation);   Other: Other
    Sponsors:   Royal Marsden NHS Foundation Trust;   Institute of Cancer Research, United Kingdom
    Recruiting - verified November 2009

  • Condition:   Acute Asthma Exacerbation
    Interventions:   Drug: Montelukast;   Drug: Placebo
    Sponsors:   University of East Anglia;   Norfolk Association of Asthma Nurses;   Merck Sharp and Dohne
    Completed - verified November 2009

  • Condition:   Plaque-Type Psoriasis
    Interventions:   Drug: Clobex Spray;   Drug: Vectical Ointment;   Procedure: Excimer Laser
    Sponsor:   University of California, San Francisco
    Not yet recruiting - verified November 2009

  • Conditions:   Chemotherapy-Induced Nausea and Vomiting;   Ovarian Cancer
    Intervention:   Drug: Aprepitant/Ramosetron/Dexamethasone
    Sponsors:   Samsung Medical Center;   Merck
    Not yet recruiting - verified November 2009

  • Condition:   Liver Transplantation
    Interventions:   Drug: Advagraf;   Drug: Mycophenolate Mofetil;   Drug: Basiliximab;   Drug: Corticosteroids
    Sponsor:   Astellas Pharma Inc
    Recruiting - verified November 2009

  • Condition:   Infertility
    Interventions:   Drug: triptorelin acetate;   Drug: NaCl %0.9
    Sponsor:   V.K.V. American Hospital, Istanbul
    Terminated - verified November 2009

  • Condition:   Breast Cancer
    Interventions:   Drug: exemestane;   Drug: lapatinib
    Sponsor:   National Cancer Institute, Naples
    Not yet recruiting - verified November 2009

  • Conditions:   Dermatitis, Atopic;   Dermatitis, Contact;   Dermatitis, Seborrheic;   Psoriasis
    Interventions:   Drug: 0.5% prednisolone acetate cream;   Drug: 0.1% betamethasone valerate cream
    Sponsor:   Mantecorp Industria Quimica e Farmaceutica Ltd.
    Not yet recruiting - verified November 2009

  • Condition:   Familial or Severe Hypercholesterolemia
    Interventions:   Dietary Supplement: flaxseed;   Dietary Supplement: whole wheat flour
    Sponsor:   The Hospital for Sick Children
    Recruiting - verified November 2009

  • Condition:   Infertility
    Interventions:   Drug: Microdose GnRh;   Drug: Flare up
    Sponsor:   Royan Institute
    Recruiting - verified November 2009

  • Conditions:   Stress Physiology;   Staff Work Load;   Artificial Pneumoperitoneum;   Anuria
    Intervention:   Behavioral: IPP
    Sponsors:   Hannover Medical School;   Dresden University of Technology;   University of Zurich
    Completed - verified November 2009

  • Condition:   Prostate Cancer
    Interventions:   Dietary Supplement: tomato-soy juice;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: therapeutic conventional surgery
    Sponsors:   Arthur G. James Cancer Hospital & Richard J. Solove Research Institute;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Condition:   Contraception
    Intervention:  
    Sponsors:   Center for Epidemiology and Health Research, Germany;   Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma
    Recruiting - verified November 2009

  • Condition:   Multiple Myeloma
    Intervention:   Drug: Lenalidomide, Pioglitazone, dexamethasone, treosulfan
    Sponsors:   University of Regensburg;   ClinAssess GmbH
    Recruiting - verified November 2009

  • Condition:   Leukemia
    Interventions:   Drug: choline magnesium trisalicylate;   Drug: dexamethasone;   Drug: tetradecanoylphorbol acetate;   Other: laboratory biomarker analysis
    Sponsors:   Cancer Institute of New Jersey;   National Cancer Institute (NCI)
    Recruiting - verified October 2009

  • Condition:   Diffuse Large B-cell Lymphoma
    Interventions:   Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Vincristine;   Drug: Prednisone;   Drug: Doxorubicin
    Sponsor:   Fondazione Intergruppo Italiano Linfomi Onlus
    Not yet recruiting - verified November 2009

  • Condition:   Urinary Calculus
    Intervention:   Drug: progesterone,tamsulosin,propantheline Bromide and nifedipine
    Sponsor:   Chongqing Medical University
    Recruiting - verified November 2009

  • Condition:   Cancer
    Intervention:   Drug: Valproic Acid
    Sponsor:   University of Utah
    Not yet recruiting - verified November 2009

  • Condition:   Infertility
    Intervention:  
    Sponsors:   University Reproductive Associates;   Ferring Pharmaceuticals
    Recruiting - verified October 2009

  • Condition:   Spinocerebellar Degeneration
    Interventions:   Drug: KPS-0373;   Drug: Placebo
    Sponsor:   Kissei Pharmaceutical Co., Ltd.
    Recruiting - verified October 2009

  • Condition:   Polycystic Ovary Syndrome
    Interventions:   Drug: combined N-acetyl cysteine -CC;   Drug: combined metformin-CC
    Sponsor:   Mansoura University
    Completed - verified November 2009

  • Conditions:   Proctitis;   Proctosigmoiditis
    Interventions:   Drug: Budesonide;   Drug: Placebo
    Sponsor:   Salix Pharmaceuticals
    Not yet recruiting - verified November 2009

  • Conditions:   Proctitis;   Proctosigmoiditis
    Interventions:   Drug: Budesonide;   Drug: Placebo
    Sponsor:   Salix Pharmaceuticals
    Not yet recruiting - verified November 2009

  • Conditions:   Pregnancy;   Obesity;   Diabetes
    Intervention:   Behavioral: Nutritional counseling and twice weekly exercise groups
    Sponsor:   Sorlandet Hospital HF
    Recruiting - verified October 2009

  • Conditions:   Ovulatory Dysfunction;   Anovulation;   Ovulation Induction
    Interventions:   Drug: clomiphene citrate;   Drug: clomiphene citrate
    Sponsor:   University of Oklahoma
    Not yet recruiting - verified November 2009

  • Conditions:   Rhinitis, Allergic, Seasonal;   Asthma
    Interventions:   Drug: BI 671800 ED;   Drug: Fluticasone Propionate Nasal Spray;   Drug: Montelukast 10 mg
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Not yet recruiting - verified November 2009

  • Condition:   Prostate Cancer
    Interventions:   Drug: cyproterone acetate;   Drug: Venlafaxine;   Drug: -Medroxyprogesterone
    Sponsor:   Laboratoires Takeda
    Completed - verified November 2009

  • Condition:   Prostate Cancer
    Intervention:  
    Sponsor:   University Health Network, Toronto
    Not yet recruiting - verified October 2009

  • Conditions:   Nausea;   Vomiting
    Intervention:   Drug: Dexamethasone, Ondansetron
    Sponsor:   Yonsei University
    Recruiting - verified November 2009

  • Condition:   Osteoporosis
    Interventions:   Dietary Supplement: Small Particle Size Calcium Carbonate Supplement;   Dietary Supplement: Large Particle Size Calcium Carbonate Supplement;   Dietary Supplement: Vitamin D;   Dietary Supplement: Calcium Placebo
    Sponsor:   Purdue University
    Completed - verified October 2009

  • Conditions:   Prostate Cancer;   Metastasis
    Intervention:   Drug: ZD4054
    Sponsors:   Aarhus University Hospital;   Copenhagen Trial Unit, Center for Clinical Intervention Research
    Not yet recruiting - verified October 2009

  • Conditions:   Asthma;   Bronchial Hyperresponsiveness
    Interventions:   Drug: Beclomethasone dipropionate HFA;   Drug: placebo
    Sponsors:   Rambam Health Care Campus;   Teva Pharmaceutical Industries
    Recruiting - verified November 2009

  • Condition:   Prostate Cancer
    Interventions:   Drug: Zoledronic acid;   Drug: Placebo
    Sponsor:   Austin Health
    Not yet recruiting - verified November 2009

  • Condition:   Invasive Breast Cancer
    Intervention:   Drug: Anastrozole
    Sponsors:   Columbia University;   Avon Foundation
    Completed - verified October 2009

  • Condition:   Idiopathic Intracranial Hypertension
    Interventions:   Drug: Acetazolamide;   Drug: Placebo;   Behavioral: Formal weight loss counselling program for both treatment groups
    Sponsors:   St. Luke's-Roosevelt Hospital Center;   National Eye Institute (NEI);   University of Rochester;   University of Iowa;   University of California, Davis
    Not yet recruiting - verified October 2009
  • Find Paid Clinical Trials